4-butyrolactone has been researched along with Non-alcoholic Fatty Liver Disease in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, TQ; Deng, YF; Mao, LN; Ming, JX; Ren, H; Sun, WG; Wang, YF; Xu, QQ; Zhang, YH; Zhou, JJ; Zhou, Q | 1 |
| Tian-Qi, C; Yan-Fang, D; Yan-Yan, W; Yong-Hui, Z | 1 |
| Chang, TC; Lee, SY; Li, YF; Lin, PH; Tu, QW; Yen, IC | 1 |
| Choi, JG; Choi, YJ; Choo, M; Chung, SJ; Jeong, YS; Jin, X; Koo, HR; Lee, BH; Lee, W; Oh, MS; Park, S | 1 |
4 other study(ies) available for 4-butyrolactone and Non-alcoholic Fatty Liver Disease
| Article | Year |
|---|---|
Kinsenoside alleviates inflammation and fibrosis in experimental NASH mice by suppressing the NF-κB/NLRP3 signaling pathway.
Topics: 4-Butyrolactone; Animals; Fibrosis; Inflammation; Lipopolysaccharides; Liver; Methionine; Mice; Mice, Inbred C57BL; Monosaccharides; NF-kappa B; NLR Family, Pyrin Domain-Containing 3 Protein; Non-alcoholic Fatty Liver Disease; Signal Transduction; Transforming Growth Factor beta1 | 2022 |
Butyrolactone I attenuates inflammation in murine NASH by inhibiting the NF-κB signaling pathway.
Topics: 4-Butyrolactone; Animals; Disease Models, Animal; Inflammation; Lipopolysaccharides; Liver; Mice; Mice, Inbred C57BL; NF-kappa B; Non-alcoholic Fatty Liver Disease; Signal Transduction | 2022 |
4-Acetylantroquinonol B ameliorates nonalcoholic steatohepatitis by suppression of ER stress and NLRP3 inflammasome activation.
Topics: 4-Butyrolactone; Animals; Cyclohexanones; Endoplasmic Reticulum Stress; Male; Mice; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; RAW 264.7 Cells; Receptors, Cell Surface | 2021 |
Z-ligustilide and n-Butylidenephthalide Isolated from the Aerial Parts of Angelica tenuissima Inhibit Lipid Accumulation In Vitro and In Vivo.
Topics: 4-Butyrolactone; Angelica; Animals; Diet, High-Fat; Drug Evaluation, Preclinical; Gene Expression Regulation; Hep G2 Cells; Humans; Lipid Metabolism; Lipogenesis; Male; Mice, Inbred C57BL; Non-alcoholic Fatty Liver Disease; Oleic Acid; Phthalic Anhydrides; Plant Components, Aerial; Plant Extracts; Sterol Regulatory Element Binding Protein 1 | 2019 |